Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Carrier Global Corporation in connection with a sale of 9.25 million B shares in Beijer Ref AB (publ)
Mandate

Vinge has advised Carrier Global Corporation in connection with a sale of 9.25 million B shares in Beijer Ref AB (publ)

September 23, 2020 Capital Markets and Public M&A

Vinge has advised Carrier Global Corporation in connection with a sale of 9.25 million B shares in Beijer Ref AB (publ) through an accelerated equity offering, with a total transaction value of approximately SEK 2.7 billion

Carrier Global Corporation (“Carrier”) is a leading global provider of heating, ventilating and air conditioning (HVAC), refrigeration, fire, security and building automation technologies, and is listed on the New York Stock Exchange.

Beijer Ref AB (publ) (“Beijer Ref”) provides commercial and industrial refrigeration as well as heating and air conditioning products and is listed on Nasdaq Stockholm.

The sold shares equal approximately 7.9 percent of the outstanding B shares in Beijer Ref. Following the transaction, Carrier continues to hold approximately 30 percent of the Beijer Ref B share capital, approximately 22 percent of the Beijer Ref A share capital and approximately 26 percent of the Beijer Ref total votes.

Vinge’s team consisted of Charlotte Levin, Linnéa Sellström, Anders Sundin Lundberg and Clara Sohlberg.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025